The United States Immigration and Citizenship Services (“USCIS”) has posted another Alert regarding the EB-5 immigrant investor visa. We post the complete Alert here for convenience. “On June 22, 2021, the U.S. District Court for the Northern District of California, in Behring Regional Center LLC v. Wolf, 20-cv-09263-JSC, vacated the EB-5 Immigrant
One day after announcing its policy on handling EB-5 immigrant investor petitions and applications, the United States Citizenship and Immigration Services (“USCIS”) has reversed its decision on accepting Form I-485, Application to Register Permanent Residence or Adjust Status (“Form I-485”). The updated “Alert” with this change has been posted on
The United States Citizenship and Immigration Services (“USCIS”) has posted an “Alert” on its “Approved EB-5 Immigrant Investor Regional Centers webpage”. The Alert explains how the USCIS will handle relevant petitions and applications following the sunset of the Immigrant Investor “Regional Center” Program (the “Program”). We emphasis herein guidance related
The EB-5 Immigrant Investor “Regional Center” Program (“Program”) will lapse on June 30, 2021 due to the failure of the U.S. Congress to reauthorize or extend it before the expiration date. Because the Senate has adjourned for recess until July 12, 2021, the Program will remain unavailable as no legislation
Update: The Department of State has updated their triad approach. For more information, click here. After enduring the COVID-19 pandemic for over a year, most U.S. embassies and consulates are not operating at full capacity. Due to limited appointment availability, a significant backlog was created for immigrant (IV) and nonimmigrant visa
Starting Sept. 4, 2021, the United States Citizenship and Immigration Services (“USCIS”) is extending the time that receipt notices can be used to show evidence of status from 18 months to 24 months for petitioners who properly filed Form I-751, Petition to Remove Conditions on Residence and Form I-829, Petition
To protect the health of U.S. citizens, permanent residents, and other people in the United States from communicable diseases, intending immigrants to the United States are required to be vaccinated against certain diseases to receive an immigrant visa. The diseases currently required to be vaccinated against are: Diphtheria Tetanus Pertussis
The United States Department of State (“DOS”) has announced updates to the tiered approach to remove backlogs and resume normal consular operations at embassies and consulates that have been severely impacted by the COVID-19 pandemic. According to DOS, Tier 1, which includes immediate relative intercountry adoption visas and age-out cases
The People’s Committee of Ho Chi Minh City has announced a full lockdown of the city until at least September 15th. As a result, the U.S. Consulate in Ho Chi Minh City is unable to process routine visa appointments and can only grant visa appointment requests in extraordinary circumstances such
United States licensed attorneys representing clients before the Department of Homeland Security (“DHS”) or the Department of State (“DOS”) submit a Form G-28 Notice of Entry of Appearance as Attorney or Accredited Representative (“Form G-28”). Submitting a Form G-28 notifies DHS and DOS that this person is being represented by
Beginning October 1, 2021, all immigrant visa applicants will be required to receive a COVID-19 vaccine as a medical clearance prerequisite. Medical evaluations, which are regulated by the United States Centers for Disease Control (“CDC”), require immigrant visa applicants to meet certain health and vaccination standards before an immigrant visa
Copyright 2012 – 2024 Enterline and Partners Consulting | All Rights Reserved
